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Following rapid, global clonal dominance of hypervirulent ribotypes, Clostridium difficile now 
constitutes the primary infectious cause of nosocomial diarrhoea. Evidence indicates at least three 
possible mechanisms of hypervirulence that facilitates the successful invasion of these atypical 
strains: 1) increased infectiousness relative to endemic strains; 2) increased symptomatic disease 
rate relative to endemic strains; and 3) an ability to outcompete endemic strains in the host’s gut. 
Stochastic simulations of an infection transmission model demonstrate clear differences between 
the invasion potentials of C. difficile strains utilising the alternative hypervirulence mechanisms, and 
provide new evidence that favours certain mechanisms (1 and 2) more than others (3). Additionally, 
simulations illustrate that direct competition between strains (inside the host’s gut) is not a 
prerequisite for the sudden switching that has been observed in prevailing ribotypes; previously 
dominant C. difficile strains can be excluded by hypervirulent ribotypes through indirect (exploitative) 
competition.
Clostridium difficile is a globally significant enteric pathogen with rapid emergence in the Americas, Asia, 
Oceania and Europe1. It is reported to be the leading cause of infectious diarrhoea in healthcare facilities 
of developed nations2, and the burden of disease caused by this pathogen is receiving increasing recogni-
tion. Disease severity ranges from asymptomatic infection to potentially fatal conditions including toxic 
megacolon, bowel perforation and sepsis.
In 2005, when performing a Europe-wide survey of 38 hospitals in 14 countries, the European Study 
Group of C. difficile found a novel ribotype (BI/NAP1/027) in Ireland, the Netherlands and Belgium3. 
Within 3 years this PCR ribotype had spread to at least 16 European countries4 and was rapidly becom-
ing one of the more prominent strains in North America5.
 
Ribotype 027 was the causative agent of the largest C. difficile epidemic recorded to date, in which 
over 2000 fatalities occurred in Quebec, Canada during 2005. Early reports of this outbreak described 
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higher-than-expected rates of morbidity and mortality associated with ribotype 027, giving rise to the 
term “hypervirulent” to distinguish this strain (and, subsequently, other strains such as ribotype 078) 
from “typical” endemic strains. Clear disambiguation between hypervirulent and typical strains is cur-
rently precluded by incomplete understanding of what causes some strains to generate outbreaks with 
substantial morbidity. We use ribotype 027 to demonstrate the invasion dynamics of hypervirulent strains 
because it was the causative agent of the largest recorded outbreak of C. difficile and because the con-
siderable literature pertaining to this particular strain facilitates more accurate model parameterisation.
Over the past decade, research has been conducted to understand hypervirulence in C. difficile 
with no consensus reached on precise causative mechanisms. Here, three plausible explanations for the 
increased virulence associated with some newly emergent strains of the pathogen (including ribotype 
027) are summarised.
Hypervirulent strains are more infectious than endemic strains. Pathogen transmission is via 
the fecal-oral route with new infections arising from the consumption of bacterial spores. C. difficile 
spores are highly desiccation resistant and can persist on hard surfaces for as long as 5 months6,7. In vitro 
studies conducted by Merrigan and colleagues8 examined the accumulation of spores over the bacterial 
growth cycle and demonstrated that hypervirulent strains sporulated earlier and accumulated signifi-
cantly more spores per total volume of culture than non-hypervirulent strains. This increased rate of 
sporulation may explain, at least in part, the observation of unusually high relapse rates associated with 
hypervirulent strains (in the order of 4-fold according to Marsh et al.9) because patients are more likely to 
contaminate their local environment and subsequently re-infect themselves. However, due to recent evi-
dence to the contrary, the notion of enhanced sporulation in hypervirulent strains remains contentious10.
Hypervirulent strains result in a higher rate of symptomatic disease. Following ingestion of 
the dormant bacterial stage, the C. difficile spore germinates on exposure to bile salts in combination 
with L-glycine11,12. Vegetative growth of the bacterium occurs during colonization of the host’s gut. While 
colonization is a prerequisite of disease, most colonized individuals remain asymptomatic. Clinical man-
ifestations of C. difficile disease are mediated through the production of toxins that are cytotoxic to epi-
thelial cells of the large intestine, causing extensive colonic inflammation and epithelial tissue damage to 
the host13. Studies conducted by Pépin and colleagues14 and Hubert et al.15 both describe a doubling in 
the rate of complicated cases (severe disease) during the rise of ribotype 027 in Canada. Higher rates in 
symptomatic disease associated with hypervirulent strains have been postulated to result from increased 
toxin production16,17 or possibly through heightened activity in variant forms of clostridial toxins18. It 
is important to note that there is also contention surrounding the notion of more disease (relative to 
asymptomatic carriage) and worse disease outcomes from hypervirulent infections19,20.
Hypervirulent strains can outcompete endemic strains in the host’s gut. Recently, Robinson 
and colleagues (2014) tested the hypothesis that vegetative cells of hypervirulent C. difficile strains could 
outcompete endemic strains for niche space. Four ribotype 027 clinical isolates and clinical isolates of 
four other strains (001, 002, 014 and 053) were pairwise tested in human fecal bioreactors and in a 
humanized microbiota mouse model. Ribotype 027 strains outcompeted endemic strains both in vitro 
and in vivo and the authors postulated that this competitive advantage is key to the overrepresentation 
of 027 in recent outbreaks21.
To offer unique perspective to the critical epidemiological question of which mechanism underlies 
the rapid global spread (and for many regions, the subsequent clonal dominance) of ribotype 027, we 
analysed the simulated invasion of hypervirulent C. difficile following its introduction into a human 
community.
Methods
A Direct Gillespie algorithm was scripted in Matlab® software version 7.12 to simulate the epidemiolog-
ical state transitions involved in C. difficile infection with endemic and hypervirulent strains. The sim-
ulated introduction of a hypervirulent strain into a community already harbouring endemic C. difficile 
used transmission parameters that were informed by the clinical literature (see Table 1). Following the 
numerical recipe outlined by Keeling and Rohani (2007), an exact stochastic analogue of the following 
set of ordinary differential equations was constructed:
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The equations describe the rates of change between the different epidemiological categories as sum-
marized in Fig. 1. These categories consist of people who are unexposed to C. difficile and who are sus-
ceptible to colonization (U); exposed to endemic strains (E) or to hypervirulent strains (Eh); colonized 
with endemic strains (C) or with hypervirulent strains (Ch); and suffering symptomatic disease from 
endemic strains (D) or hypervirulent strains (Dh). The rate at which individuals are infected is governed 
by the transmission coefficient (β ). Once infected, individuals subsequently become colonized by the 
pathogen at rate ‘η ’. Most of these individuals will remain asymptomatic (determined by parameter ε ) 
until the infection resolves and will re-enter the ‘unexposed’ category. The remaining individuals who go 
on to experience symptomatic CDI either self-resolve (re-entering the unexposed category), or revert to 
asymptomatically colonized or they die (according to rate μ ). Births are set to perfectly balance deaths 
to maintain a stable human population, φ = μ (D + Dh). The parameters governing the rates of change 
and the associated proportions are described in Table 1.
The key mechanisms by which hypervirulent strains differ from normal endemic strains are: 1) the 
rate of transmission is higher for hypervirulent strains (β h > β ); 2) the proportion that experience symp-
tomatic disease is higher for hosts infected with hypervirulent strains (ε h > ε ); and 3) individuals that 
are already colonized with normal endemic strains can be colonized by hypervirulent strains (α > 0). To 
ascertain the effects of these three alternative mechanisms, 1000 stochastic introductions of a hypervir-
ulent strain into a community that already harboured normal endemic C. difficile at stable equilibrium 
was simulated. Several epidemiologically relevant metrics were evaluated: the proportion of introduc-
tions that elicited an epidemic; the speed at which the newly introduced strain equilibrated; and the 
Symbol Definition Value Ref.
βh : β
Transmission coefficient (hypervirulent:endemic 
strain) MECHANISM 1 1–1.5
Full range tested 
in simulations
εh : ε 
Develop symptoms (proportion) 
(hypervirulent:endemic strain); MECHANISM 2 1–1.5
α Hypervirulent strain’s ability to supplant colonized endemic; MECHANISM 3 0–1
1-ε Colonization self-clearance (proportion) 0.8 40
η Develop into asymptomatic but Infectious state (day−1) 0.2
41
θ Develop symptomatic CDI (day−1) 0.2 40
ζ CDI self-resolve (proportion) 0.33 42
τ CDI self-resolve rate (day−1) 0.5 43
ρ CDI treatment (day−1) 0.1 44
σ Treatment failure (proportion) 0.2 45
μ Mortality rate (day−1) 0.0012 40
Table 1.  Epidemiological model symbology and parameterisation.
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new equilibrium prevalence level following successful invasion, across a broad range of the parameters 
governing the different mechanisms of hypervirulence.
Results
Establishment (i.e. successful invasion) of hypervirulent strains was more likely for higher simulated lev-
els of infectiousness (left axis, Fig. 2). For example, an invading strain that is 50% more infectious than 
endemic strains successfully established in 31.6% of simulations, compared with a strain that is only 20% 
more infectious which established in 13.8% of simulations. Similarly, hypervirulent strains that elicited a 
higher symptomatic rate in colonized individuals and that were capable of infecting individuals already 
colonized by normal endemic strains were more likely to establish. For example, 11.8% of invasions 
established for hypervirulent strains eliciting a 50% increase in the symptomatic rate relative to typical 
endemic strains whereas only 3.8% of invasions established with strains eliciting a 20% increase in the 
symptomatic rate relative to endemic strains. Seven percent of hypervirulent invasions became estab-
lished when individuals who were colonized with endemic strains were equally susceptible to infection 
as uncolonized individuals, but only 2.4% of invasions established if endemic-colonized individuals were 
only one-fifth as susceptible to hypervirulent infection as uncolonized individuals.
Hypervirulence modelled through increased transmission potential, or through increased sympto-
matic infection rate, also had a positive relationship with the new equilibrium level established by the 
Figure 1. The Clostridium difficile epidemiological state transitions simulated by the stochastic 
model. The left column details colonisation with ‘typical’ endemic strains and the right column details 
colonisation with hypervirulent strains. From reviewing the literature, three possible areas were identified 
that differentiated transitions in hypervirulent strains from endemic strains: 1) Hypervirulent strains are 
more infectious (modelled by increasing the transmission coefficient); 2) Hypervirulent strains give rise to a 
higher symptomatic rate; and 3) Hypervirulent strains can outcompete endemic strains in the host’s gut.
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invading pathogen (right axis, Fig. 2). For example, an increased infectiousness associated with hyper-
virulence of 20% led to a new equilibrium prevalence of 3.2 symptomatic infections per 10,000 individ-
uals (s.d. 0.5) compared to a 50% increased infectiousness which led to new equilibrium prevalence of 
4.4 symptomatic infections per 10,000 individuals (s.d. 0.7). However, the third modelled mechanism 
of hypervirulence (an ability of hypervirulent strains to displace endemic strains within the host gut) 
showed no apparent relationship with the resultant new equilibrium prevalence.
The speed of establishment had a positive relationship with the level of hypervirulent strain infec-
tiousness relative to endemic strains (Fig. 3); and a similar relationship was observed between establish-
ment speed and hypervirulent strains eliciting higher symptomatic rates. Again, when hypervirulence 
was modelled by allowing an ability of hypervirulent strains to displace endemic strains within the host 
gut, the relationship between speed of establishment and displacement ability was obscured (Fig. 3).
Results demonstrate that regardless of the modelled mechanism of hypervirulence, the successful 
invasion of the introduced hypervirulent strain resulted in the exclusion of the extant endemic strain 
(Fig. 4).
Discussion
Through stochastic simulation, the invasion of a hypervirulent strain of Clostridium difficile into a 
human community already harbouring an endemic strain was explored. Several mathematical models of 
C. difficile transmission have been reported22,23, most having been published in the last five years24–29. 
Figure 2. Proportion of hypervirulent Clostridium difficile introductions that successfully invade (along 
with fitted logistic regression curves; black left y-axis) and the new level to which they equilibrate 
(per 10,000 individuals, red right y-axis). Output from 1000 simulated introductions are displayed for 
each parameter level under all mechanistic scenarios. Left plot: hypervirulent strains are more infectious 
(modelled by increasing the transmission coefficient); Middle plot: hypervirulent strains give rise to a higher 
symptomatic rate; Right plot: hypervirulent strains can outcompete endemic strains in the host’s gut.
Figure 3. Frequency distribution of time (in months) taken for a newly introduced hypervirulent strain 
of Clostridium difficile to establish new equilibrium under the different mechanisms of hypervirulence. 
Output from 1000 simulated introductions are displayed for each parameter level under all mechanistic 
scenarios (note the reversed parameter axes for β and for α which was done to display results more clearly).
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The rationale behind all these previous models was to strategize the control of infection in a hospital 
setting. However, C. difficile is increasingly recognised as a pathogen of the global community, rather 
than just the subset of the community housed within healthcare facilities. Additionally, recent studies 
have suggested that the community is a major source, if not the primary source, of infections experienced 
by the high-risk groups within healthcare settings30,31. To the best of our knowledge, the current study 
constitutes the first epidemiological model of C. difficile transmission within the wider community as 
well as the first comparative analysis of alternative mechanisms of hypervirulence.
Precise causes for the difference in virulence between hypervirulent stains and endemic strains remain 
unknown despite the fact that these newer ‘atypical’ strains now constitute the majority of infections in 
the community setting32. Consequently, the effects of three different mechanisms of heightened virulence 
were tested: increased infectiousness of the pathogen, an increased rate of symptomatic disease follow-
ing colonization, and the ability of hypervirulent strains to displace endemic strains from a colonized 
gut. Intuitively, the parameters governing these different mechanisms all had positive relationships with 
the probability of an invading strain establishing in the community. However, comparing the influence 
of these parameters on the rate of invasion and the resultant equilibrium prevalence yielded strikingly 
different epidemiological patterns.
In line with classic epidemiological understanding33, the rate at which an introduced pathogen 
spreads among a susceptible population is highly dependent on the transmission coefficient, which was 
modelled by increasing the infectiousness of a hypervirulent strain. Simulations showed that more infec-
tious strains were more likely to establish, spread more rapidly, and equilibrated to a higher prevalence 
within the community. The likelihood of successful invasion and the new steady state prevalence were 
both less dramatically influenced by increasing the colonized proportion that went on to experience 
clinical disease. When individuals colonized with endemic strains were susceptible to colonization with 
Figure 4. Successfully invading hypervirulent strains of Clostridium difficile (left column, red) 
competitively exclude pre-existing endemic strains (right column, blue). The fold increase in 
infectiousness relative to endemic strains is shown in the top left of the hypervirulent plots. A one-month 
moving average of the successful hypervirulent strain invasions from 1000 simulated introductions are 
displayed (with shaded 95% confidence intervals).
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hypervirulent strains (the third modelled mechanism of hypervirulence) a much weaker relationship 
was found with likelihood of establishment, and no clear relationship was seen with the resulting equi-
librium prevalence. This is because the spread of the newly introduced strain is essentially independent 
of the resident strain endemicity when a resident strain-colonized gut is colonized just as readily as an 
uncolonized gut. Consequences of this finding for the strategy to reduce hypervirulent spread through 
artificial infection with non-toxigenic strains require exploration.
Clinical reports during the past 15 years have described significantly increased rates of disease corre-
sponding with a pronounced and rapid shift in C. difficile strain dominance. PCR-ribotyping of isolates 
from a Montreal area hospital demonstrated that NAP1/ribotype 027 was absent in 2000 and 2001 but 
represented more than 75% of all isolates corresponding with an outbreak in 2003–200434. Increased 
disease prevalence has corresponded with the dominance of ribotype 027 in numerous countries across 
the world including in England where it peaked in 2007–200835, in Europe36 and North America37.
Tying this epidemiological picture in with the results of the current analysis, it appears that an abil-
ity of hypervirulent strains to displace endemic strains from the already-colonized host gut is the least 
likely mechanism facilitating dominance of ribotype 027. Despite testing a broad range of parameter 
values, from complete colonization resistance to susceptibility equivalent to an uncolonized individual, 
the newly introduced strain failed to reproduce the heightened prevalence level associated with emerging 
hypervirulent strains. This finding does not negate the possibility that hypervirulent strains are more 
competitive within-host than more typical strains; but it does suggests that this mechanism is not key to 
the successful invasion and clonal dominance of hypervirulent strains such as ribotype 027. Importantly, 
the current study demonstrated that direct competition between strains (inside the host’s gut) is not a 
prerequisite for the sudden switching in prevailing strains; simulations of all alternative hypervirulence 
mechanisms clearly illustrated that previously dominant strains are not simply added to following new 
strain invasion, but are excluded through indirect (exploitative) competition.
Transmission dynamics of the remaining alternative hypervirulence mechanisms (increased infec-
tiousness and increased symptomatic disease) are much more similar and, therefore, will be much more 
difficult to disentangle. It is likely that distinguishing between the remaining alternatives will not be 
possible from comparisons of simulation output with longitudinal, ribotyped infection data, and will 
necessitate a much clearer clinical picture of C. difficile infection. When these data become available in 
the future and/or there is increasing evidence derived through alternative means that favours a particular 
mechanism of hypervirulence, the current model formulation offers an important epidemiological tool 
for contributing towards infection control strategy. These developments will in turn allow for better 
refinement of the model to account for the interaction between host (as well as bacterial) factors involved 
in pathogenesis.
There are a number of limitations to the current study that warrant discussion. Despite burgeoning 
interest in this pathogen of global health significance, basic metrics of the infection process, such as latent 
periods, are scant in the literature38. Due to limited information on the life history of C. difficile infec-
tion, parameterisation of the current model has depended on numbers amassed from multiple studies 
across multiple epidemiological settings. This is a common issue with biologically realistic simulation 
modelling39. While a substantial effort was made in preferentially selecting recent studies that better 
reflected the pathogen’s modern epidemiology (published within the past 5 years) as sources of parameter 
estimates, this was not always possible. Another important limitation is that it has been assumed that the 
alternative hypervirulence mechanisms operate in a mutually exclusive manner when, in reality, several 
mechanisms might interact synergistically. Perhaps the most important limitation is the absence of lon-
gitudinal ribotype data for a newly invading hypervirulent strain with which to fit our simulation model. 
The current study using the most up-to-date clinical and microbiological information demonstrates that 
a complete switch in the dominant ribotype can take place in as little as 6 months. This highlights not 
only the frequency at which ribotype data would require collection to capture invasion dynamics but 
also the necessity for an extremely rapid, active surveillance response following initial hypervirulent 
detection.
Over the past 15 years, morbidity and mortality resulting from C. difficile has steadily increased 
worldwide as a function of the emergence of hypervirulent strains (most notably, ribotype 027). There 
is contention surrounding all currently proposed mechanisms distinguishing hypervirulent strains from 
more typical (less virulent) predecessor strains; how this pathogen has become the leading cause of infec-
tious nosocomial diarrhoea remains unknown. In addition to providing new evidence that clearly favours 
certain hypervirulence mechanisms over others, the current analysis constitutes the first epidemiological 
model to explore the dynamics of C. difficile outside of a healthcare setting by simulating pathogen 
spread within the wider human community – an aspect that is widely regarded to be critical to the 
pathogen’s modern epidemiology. Methods described in this foundational study provide an important 
contribution to future outbreak analysis of this disease of increasing global relevance.
References
1. He, M. et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat. Genet. 45, 109–113 
(2013).
2. Kelly, C. P. & LaMont, J. T. Clostridium difficile—more difficult than ever. New Engl. J. Med. 359, 1932–1940 (2008).
www.nature.com/scientificreports/
8Scientific RepoRts | 5:12666 | DOi: 10.1038/srep12666
3. Barbut, F. et al. Prospective study of Clostridium difficile-associated disease in Europe with phenotypic and genotypic 
characterization of the isolates. Clin. Microbiol. Infect. 13, 1048–1057 (2007).
4. Kuijper, E. J. et al. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe. Eurosurveil. 13, e18942 (2008).
5. Freeman, J. et al. The Changing Epidemiology of Clostridium difficile Infections. Clin. Microbiol. Rev. 23, 529–549 (2010).
6. Fekety, R. et al. Epidemiology of antibiotic-associated colitis: isolation of Clostridium difficile from the hospital environment. 
Am. J. Med. 70, 906–908 (1981).
7. Gerding, D. N., Muto, C. A. & Owens, R. C. Measures to Control and Prevent Clostridium difficile Infection. Clin. Infect. Dis. 
46, S43–S49 (2008).
8. Merrigan, M. et al. Human Hypervirulent Clostridium difficile Strains Exhibit Increased Sporulation as Well as Robust Toxin 
Production. J. Bacteriol. 192, 4904–4911 (2010).
9. Marsh, J. W. et al. Association of Relapse of Clostridium difficile Disease with BI/NAP1/027. J. Clin. Microbiol. 50, 4078–4082 
(2012).
10. Burns, D. A., Heeg, D., Cartman, S. T. & Minton, N. P. Reconsidering the Sporulation Characteristics of Hypervirulent 
Clostridium difficile BI/NAP1/027. PLoS ONE 6, e24894 (2011).
11. Paredes-Sabja, D., Shen, A. & Sorg, J. A. Clostridium difficile spore biology: sporulation, germination, and spore structural 
proteins. Trends Microbiol. 22, 406–16 (2014).
12. Sorg, J. A. & Sonenshein, A. L. Bile salts and glycine as co-germinants for Clostridium difficile spores. J. Bacteriol. 190, 2505–2512 
(2008).
13. Voth, D. & Ballard, J. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18, 247–263 
(2005).
14. Pépin, J. et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease 
severity. Canad. Med. Assoc. J. 171, 466–472 (2004).
15. Hubert, B. et al. A Portrait of the Geographic Dissemination of the Clostridium difficile North American Pulsed-Field Type 1 
Strain and the Epidemiology of C. difficile-Associated Disease in Québec. Clin. Infect. Dis. 44, 238–244 (2007).
16. Warny, M. et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in 
North America and Europe. The Lancet 366, 1079–1084 (2005).
17. Vohra, P. & Poxton, I. Comparison of toxin and spore production in clinically relevant strains of Clostridium difficile. Microbiol. 
157, 1343–1353 (2011).
18. Lanis, J., Barua, S. & Ballard, J. Variations in TcdB activity and the hypervirulence of emerging strains of Clostridium difficile. 
PLoS Path. 6, e1001061 (2010).
19. Morgan, O. W. et al. Clinical Severity of Clostridium difficile PCR Ribotype 027: A Case-Case Study. PLoS ONE 3, e1812 (2008).
20. Sirard, S., Valiquette, L. & Fortier, L.-C. Lack of Association between Clinical Outcome of Clostridium difficile Infections, Strain 
Type, and Virulence-Associated Phenotypes. J. Clin. Microbiol. 49, 4040–4046 (2011).
21. Robinson, C. D., Auchtung, J. M., Collins, J. & Britton, R. Epidemic Clostridium difficile strains demonstrate increased 
competitive fitness over non-epidemic isolates. Infect. Immun. 82, 2815–25 (2014).
22. Starr, J. M. & Campbell, A. Mathematical modeling of Clostridium difficile infection. Clin. Microbiol. Infect. 7, 432–437 (2001).
23. Starr, J. M., Campbell, A., Renshaw, E., Poxton, I. R. & Gibson, G. J. Spatio-temporal stochastic modelling of Clostridium difficile. 
J. Hosp. Infect. 71, 49–56 (2009).
24. Rubin, M. A. et al. A Simulation-Based Assessment of Strategies to Control Clostridium Difficile Transmission and Infection. 
PLoS ONE 8, e80671 (2013).
25. Codella, J., Safdar, N., Heffernan, R. & Alagoz, O. An Agent-based Simulation Model for Clostridium difficile Infection Control. 
Med. Dec. Making 35, 211–29 (2015).
26. Lanzas, C. & Dubberke, D. Effectiveness of screening hospital admissions to detect asymptomatic carriers of Clostridium difficile: 
a modeling evaluation. Infect. Control Hosp. Epidemiol. 35, 1043–1050 (2014).
27. Lanzas, C., Dubberke, E. Lu, Z., Reske, K. & Gröhn, Y. Epidemiological Model for Clostridium difficile Transmission in 
Healthcare Settings. Infect. Control Hosp. Epidemiol. 32, 553–561 (2011).
28. Yakob, L., Riley, T., Paterson, D. & Clements, A. Clostridium difficile exposure as an insidious source of infection in healthcare 
settings: an epidemiological model. BMC Infect. Dis. 13, 376 (2013).
29. Yakob, L., Riley, T. V., Paterson, D. L., Marquess, J. & Clements, A. C. A. Assessing control bundles for Clostridium difficile: a 
review and mathematical model. Emerg Microbes Infect 3, e43; doi: 10.1038/emi.2014.43 (2014).
30. Walker, A. S. et al. Characterisation of Clostridium difficile Hospital Ward–Based Transmission Using Extensive Epidemiological 
Data and Molecular Typing. PLoS Med 9, e1001172 (2012).
31. Eyre, D. W. et al. Diverse Sources of C. difficile Infection Identified on Whole-Genome Sequencing. New Engl. J. Med. 369, 
1195–1205 (2013).
32. Bignardi, G. E. & Settle, C. Different ribotypes in community-acquired Clostridium difficile. J. Hosp. Infect. 70, 96–98 (2008).
33. Kermack, W. O. & McKendrick, A. G. A Contribution to the Mathematical Theory of Epidemics. Proc. Roy. Soc. A 115, 700–721 
(1927).
34. MacCannell, D. et al. Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada. 
J. Clin. Microbiol. 44, 2147–2152 (2006).
35. Wilcox, M. H. et al. Changing Epidemiology of Clostridium difficile Infection Following the Introduction of a National 
Ribotyping-Based Surveillance Scheme in England. Clin. Infect. Dis. 55, 1056–1063 (2012).
36. Bauer, M. P. et al. Clostridium difficile infection in Europe: a hospital-based survey. The Lancet 377, 63–73 (2011).
37. O’Connor, J. R., Johnson, S. & Gerding, D. N. Clostridium difficile Infection Caused by the Epidemic BI/NAP1/027 Strain. 
Gastroenterol. 136, 1913–1924 (2009).
38. Otete, E. H. et al. Parameters for the Mathematical Modelling of Clostridium difficile Acquisition and Transmission: A Systematic 
Review. PLoS ONE 8, e84224 (2013).
39. Keeling, M. & Rohani, P. Modeling infectious diseases in humans and animals. (Princeton University Press, 2008).
40. Loo, V. G. et al. Host and Pathogen Factors for Clostridium difficile Infection and Colonization. New Engl. J. Med. 365, 1693–1703 
(2011).
41. Rafii, F., Sutherland, J. B. & Cerniglia, C. E. Effects of treatment with antimicrobial agents on the human colonic microflora. 
Therap. Clin. Risk Manag. 4, 1343–1358 (2008).
42. Bartlett, J. G. Treatment of antibiotic-associated pseudomembranous colitis. Rev. Infect. Dis. 6, S235–S241 (1984).
43. CDC. Frequently Asked Questions about Clostridium difficile for Healthcare Providers. < http://www.cdc.gov/hai/organisms/cdiff/
cdiff_faqs_hcp.html> (2010) (Date of access:31/10/2014).
44. McFarland, L. V. Update on the changing epidemiology of Clostridium difficile-associated disease. Nat. Clin. Pract. Gastroenterol. 
Hepatol. 5, 40–48 (2008).
45. Leffler, D. A. & Lamont, J. T. Treatment of Clostridium difficile-Associated Disease. Gastroenterol. 136, 1899–1912 (2009).
www.nature.com/scientificreports/
9Scientific RepoRts | 5:12666 | DOi: 10.1038/srep12666
Aknowledgement
Funding for this study was provided by the National Health and Medical Research Council of Australia, 
grant number APP1006243. RJSM is supported by a University of Queensland Postdoctoral Research 
Fellowship. LFK is funded by an Endeavour Postgraduate Scholarship (3781_2014), an Australian 
National University Higher Degree Scholarship, and a Fondo para la Innovación, Ciencia y Tecnología 
Scholarship (095-FINCyT-BDE-2014). ACAC is funded by an Australian National Health and Medical 
Research Council Senior Research Fellowship (1058878).
Author Contributions
L.Y. conceived of the study, wrote and analysed the model. T.V.R., D.L.P. and A.C.A.C. consulted on model 
construction. L.Y., T.V.R., D.L.P., J.M., R.J.S.M., L.F.K. and A.C.A.C. contributed to the interpretation of 
model output, drafted the manuscript and approved the final manuscript.
Additional Information
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Yakob, L. et al. Mechanisms of hypervirulent Clostridium difficile ribotype 027 
displacement of endemic strains: an epidemiological model. Sci. Rep. 5, 12666; doi: 10.1038/srep12666 
(2015).
This work is licensed under a Creative Commons Attribution 4.0 International License. The 
images or other third party material in this article are included in the article’s Creative Com-
mons license, unless indicated otherwise in the credit line; if the material is not included under the 
Creative Commons license, users will need to obtain permission from the license holder to reproduce 
the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
